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ABSTRACT: Warfarin resistance was first discovered among Norway rat (Rattus norvegicus) populations in Scotland 
in 1958 and further reports of resistance, both in this species and in others, soon followed from other parts of Europe 
and the United States. Researchers quickly defined the practical impact of these resistance phenomena and developed 
robust methods by which to monitor their spread. These tasks were relatively simple because of the high degree of 
immunity to warfarin conferred by the resistance genes. Later, the second generation anticoagulants were introduced 
to control rodents resistant to the warfarin-like compounds, but resistance to difenacoum, bromadiolone and brodifacoum 
is now reported in certain localities in Europe and elsewhere. However, the adoption of test methods designed initially 
for use with the first generation compounds to identify resistance to compounds of the second generation has led to some 
practical difficulties in conducting tests and in establishing meaningful resistance baselines. In particular, the results 
of certain test methodologies are difficult to interpret in tentlS of the likely impact on practical control treatments of the 
resistance phenomena they seek to identify. This paper defines rodenticide resistance in the context of both first and 
second generation anticoagulants. It examines the advantages and disadvantages of existing laboratory and field methods 
used in the detection of rodent populations resistant to anticoagulants and proposes some improvements in the application 
of these techniques and in the interpretation of their results. 
INTRODUCTION 
The development of resistance in rodents to the 
anticoagulant rodenticides threatened the great strides 
towards improved efficacy and safety that the introduction 
of these compounds had made possible. This 
phenomenon was first discovered among Norway rats 
(Rattus norvegicus) in Scotland in 1958 (Boyle 1960) but 
the initial outbreak was quickly followed by others 
occurring in the United Kingdom (UK) (Drummond 
1966a), Denmark (Lund 1988), the United States (USA) 
(Jackson and Kaukeinen 1972) and elsewhere. Some of 
these resistance foci spread rapidly in spite of rigorously-
applied and varied attempts to overcome them. Others 
were successfully managed, either so that they 
disappeared completely or their spread was substantially 
curtailed. Still other foci seemed to disappear without 
human intervention (see Smith and Greaves 1987 for a 
review). Meanwhile, the other important commensal 
rodent pest species, the House mouse (Mus musculus/ 
domesticus), never very susceptible to the early 
anticoagulant compounds such as warfarin, diphacinone 
and coumatetralyl, also developed resistant populations in 
several countries (Wallace and MacSwinney 1976, Ashton 
and Jackson 1984). 
The discovery of the second generation compounds 
(Hadler and Shadbolt 1972) redressed the balance for 
several years but, in a few localities, resistance to the first 
generation anticoagulants brought with it a measure of 
cross resistance to the second generation compounds and 
soon populations of rats and mice began to appear with 
reduced susceptibility to these more potent compounds 
(Greaves et al. 1982). However, resistance to the modem 
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anticoagulants, such as brodifacoum, bromadiolone and 
difenacoum, has never become as widespread as that to 
the first generation compounds and nowhere is it 
impossible to control rodents with at least one of these 
materials (Buckle 1994). Nevertheless, great interest 
remains both among researchers and pest control 
practitioners in the resistance phenomenon; the former in 
their attempts to measure and record the development and 
spread of resistance in different rodent species and the 
latter in their desire to conduct effective rodent control 
programs. 
DEFINffiONS OF RESISTANCE 
The term resistance means different things to 
different people. Researchers commonly define it as •the 
development of an ability in a strain of a pest to survive 
doses of a toxicant which would prove lethal to the 
majority of individuals of a normal population of the same 
species. • In other words, if a technique can be applied 
which distinguishes between the susceptibility of 
individuals belonging to two strains of a pest species, the 
less susceptible strain may be considered •resistant.• 
Such a definition is important to those wishing to detect 
the early onset of resistance, perhaps to allow the 
implementation of measures to interrupt its spread. 
However, it gives no indication of the likely practical 
significance of the resistance phenomenon described. To 
the pest control practitioner, a statement that defines· a 
species as resistant to an anticoagulant rodenticide implies 
that the compound will be ineffective when used against 
it. But it is evident from the foregoing that this is not 
necessarily the case. 
Greaves (1994) recently conceived the following 
definition: 
Anticoagulant resistance is a major loss of 
efficacy in practical conditions where the 
anticoagulant has been applied correctly, the 
loss of efficacy being due to the presence of a 
stTain of rodent with a heritable and 
commensurately reduced sensitivity to the 
anticoagulant. 
This definition encompasses three important elements. 
Firsdy, that the phenomenon described as resistance 
should involve a significant change in susceptibility that 
brings about a practical effect. Thus, where the tenn 
resistance is applied to a compound and pest species, 
practitioners should anticipate a real loss of efficacy at the 
resistance focus. Secondly, that the compound should 
have been applied correctly and, incidentally, be normally 
effective for the species involved. Often, when an 
anticoagulant treatment fails, the cause is attributed to 
resistance when the real reason is faulty application. 
Thirdly, that the resistance should have a genetic basis 
that makes it transmissible between rodent generations. 
If the tenn resistance is to be reserved for cases 
satisfying these criteria, what term should be used when 
a heritable change of susceptibility is observed that falls 
short of this definition in terms of its practical effect? 
Gill et al. (1992) introduced the phrase "low grade 
resistance" to describe a situation of this type. However, 
unless genetical experiments are done, it is very difficult 
to distinguish between this phenomenon and differences in 
the response of rodent populations to anticoagulants that 
would be predicted on the basis of natural variability. 
Rodenticide resistance in the sense defined by 
Greaves (1994) has been found only to the anticoagulant 
compounds. Therefore, in this paper we will restrict 
ourselves to dealing with these compounds, which are the 
basis of the majority of rodent control program 
worldwide. The main purpose of the paper is to present 
a critical review of the methods currently used in the 
detection of resistance to anticoagulants. Later we will 
look at some anticoagulant resistance phenomena detected 
in the UK and judge them against the definition of 
Greaves (1994). 
RESISTANCE DETECTION METHODS 
It quickly became apparent to those investigating 
early outbreaks of resistance to warfarin in Norway rats 
in the UK that methods were required by which to 
distinguish resistant rat infestations from normally 
susceptible ones. The two lines of research initially 
followed were described by Drummond (1966b). The 
first involved a method in which the effectiveness of field 
applications of warfarin against suspected warfarin-
resistant Norway rats were compared with the results of 
treatments against anticoagulant-naive populations. This 
technique became known as the resistance "monitoring 
graph" method and was fully described by Drummond and 
Rennison (1973). A second method was developed 
following the same principle but based on laboratory 
testing techniques. This became known as the World 
Health Organization (WHO) "lethal feeding period" test 
because its result was a discriminating dose of the 
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anticoagulant under investigation, expressed in terms of 
the number of days of consecutive feeding (the lethal 
feeding periOd or LFP}, that would kill a defined 
percentile of normally susceptible animals (WHO 1982). 
A third line of research resulted in the development of 
another laboratory resistance detection technique base 
upon differences observed in the contrasting abilities of 
the blood of warfarin-susceptible and warfarin-resistant 
rats to clot after the administration of warfarin (Martin et 
al. 1979). 
Resistance Monitoring Graph 
As a susceptible rodent population feeds on poisoned 
bait in a practical rodent control treatment, the numbers 
of takes of bait from bait points and the quantity of bait 
eaten increases at first and then quickly decreases as the 
poison takes effect. Drummond and Rennison (1973) 
recorded this process in relation to three populations of 
warfarin-susceptible Norway rats exposed to either 0.005 
or 0.025 % warfarin. The data were pooled for the three 
treatments and plotted, as a regression equation, on a 
graph in which the abscissa was the day of the recording 
visit, expressed as a common logarithm, and the ordinate 
was the number of bait points with takes, expressed as a 
proportion of the number of takes recorded on the second 
day of the treatment. The 95 % confidence limits for the 
expected bait take at any given time were calculated and 
also plotted. The derived graph therefore illustrates the 
expected effect of the application of warfarin against 
susceptible Norway rats infesting UK farmsteads. 
The results of treatments, in which the susceptibility 
status of the infestation is unknown, may be plotted on 
the derived graph as a test for the presence of resistance. 
If the decline in bait takes with time follows the nonnal 
course, and the plotted line remains within the 95 % 
confidence limits, the treated population is determined to 
be warfarin-susceptible. If the plotted line moves outside 
the upper 95 % confidence limit for two successive baiting 
visits, the infestation is considered warfarin-resistant. 
However, the confidence limits chosen will give this 
result by chance alone on one occasion in forty and for 
this reason, and others, the authors recommended 
confirmatory laboratory test to be carried out on captured 
survivors of unsuccessful treatments. This method was 
widely used in the UK, not only for establishing the 
susceptibility status of suspected resistant populations but 
also as a method of determining the effectiveness of 
novel, resistance-breaking rodenticides against warfarin-
resistant rat populations (e.g., Rennison and Dubock 
1978). 
The method has a number of flaws, both practical 
and statistical in nature. Rennison (1977) pointed out that 
complete cessation of feeding did not necessarily indicate 
that the rat infestation had been extinguished unless a 
careful examination of the site confirmed no other signs 
of continuing rat activity. The studies of Quy et al. 
(1992) have further emphasized the need for care in the 
interpretation of results when the effectiveness of 
treatments is assessed only by bait take data. 
While experience has proven the original monitoring 
graph to have been robust for its purpose, there is 
considerable potential for improving its statistical basis. 
When data are pooled from several sites to obtain a single 
regression line there must be confidence that the data 
employed are homogeneous. In this case, the three farm 
sites and the results Drummond and Rennison obtained 
from them show clear signs of heterogeneity 
(notwithstanding the obvious fact that, at one site, the 
concentration of warfarin in the bait differed from that 
used at the other two). This implies that the expected 
relationship between the decline in the number of bait 
takes and time is not fixed but may vary from one site to 
another. The authors also neglected the fact that the 
width of the 95 % confidence limits would be expected to 
differ depending on the number of bait points monitored 
on the farms (i.e., sample size); the limits being wider for 
farms with smaller numbers of points. Furthermore, the 
regression equation applied assumed a linear relationship 
between log time and the numbers of bait takes. There is 
evidence that the relationship observed better fits a curve 
and, therefore, a suitable transformation should have been 
applied or a non-linear model fitted to the data. 
In spite of these drawbacks, the monitoring graph 
offers the most easily interpreted positive indication of the 
existence of a resistant rat infestation. That is, when the 
rodenticide in question is used, as directed, against a 
natural pest infestation, it demonstrably fails to provide an 
acceptable level of control in comparison to its 
performance against a fully susceptible rat population. Of 
course, further laboratory work on the inheritance of the 
resistance trait is rQquired before the definition of Greaves 
(1994) is fully satisfied. 
World Health Organiz.ation (WHO) Lethal Feeding Period 
Test 
This second methodology employs the same basic 
principles as the previous technique but the 
experimentation is laboratory-based. A susceptibility 
base-line is established using wild-captured animals from, 
preferably, anticoagulant-naive populations. Groups of 
these animals are fed, for differing numbers of days, a 
no-choice diet comprising a bait containing the poison 
under study at the strength normally used in control 
programmes. A dose-response curve is constructed in a 
similar way to that employed in tests to determine the 
acute oral LD50 of a compound but, in this case, feeding 
periods in days are used as the dose variable instead of 
differing quantities of active ingredient. Thus, lethal 
feeding period (LFP) percentiles are calculated rather than 
lethal dose (LD) percentiles. 
This process is typified by the work of Buckle et al. 
(1980) to establish the susceptibility of the South-east 
Asian rice rat (Rartus argentiventer) to baits containing 
0 .025% warfarin. No-choice feeding periods of 2 , 4, 6, 
8, 10 and 12 days gave mortalities of 27.5, 57.5, 82.5, 
87.5, 97.5 and 100% respectively. These data were used 
to construct a dose-response curve and, following WHO 
Guidelines (WHO 1982), the LFP99 was calculated to be 
15.1 days, giving a 16-day no-choice feeding period on 
0.025% warfarin bait as the checking test for resistance 
in this species (Buckle 1983). 
The recommended statistical method for the analysis 
of these data (WHO 1982) is that of Finney (1971), in 
which the dose variable (days) is expressed as a logarithm 
and the response variable (percent mortality) as a probit. 
However, other models for instance involving logit 
mortality and absolute time rather than log time are 
arguably equally appropriate. The effect of the model 
used is apparent when the data of Buckle et al. (1980) are 
examined using each of the four possible models (Table 
1). 
There is no obvious biological reason why any one 
of the models used in Table 1 is more correct than any 
other. Nor does any of the four calculated dose-response 
relationships fit the observed data better than any other. 
Thus, at the LFP99 percentile recommended by the WHO, 
discriminating doses ranging from 11 days to 20 days are 
equally valid. In this unsatisfactory situation it is 
prudent, therefore, to adopt a less extreme LFP percentile 
at which the effect of the model used is unimportant. For 
example, Table 1 shows the discriminating dose to be 
eight days for all four models at the LFP90• The use of 
this percentile has the additional benefits that the feeding 
tests are of shorter duration and that the discriminating 
dose is derived by interpolation rather than by the less 
reliable method of extrapolation. 
The WHO lethal feeding period test has been widely 
applied to first generation anticoagulants and to one of the 
second generation compounds (i .e. , difenacoum, Redfern 
and Gill 1978). However, difficulties are encountered 
when using the technique to derive discriminating doses 
to detect resistance to the more potent compounds. This 
is because the steep slope of the dose-response curve does 
not allow sufficient data points for proper statistical 
analysis (Gill and MacNicoll 1991). For example, all 
susceptible Norway rats succumb to a single day of 
feeding on 0 .005% brodifacoum and tlocoumafen baits 
(Buckle 1994). In this case, the WHO guidelines 
recommend that the concentration of the anticoagulant in 
the bait should be reduced to produce survivors at a 
sufficient number of dosage (days) intervals. Gill and 
MacNicoll (1991) used 0.0005% brodifacoum bait (10% 
of the concentration of active ingredient normally used in 
rodenticide treatments) to establish a discriminating dose 
of brodifacoum and pointed out the difficulty of this 
approach. However, the result was the anomalous 
situation of rats being declared "resistanr to the 
compound in spite of the fact that they succumb to baits 
containing it at full field strength (i.e. , 0.005 % ). The 
difficulty of determining the impact of this so-called 
resistance on the outcome of practical control treatments 
is readily apparent and certainly, in this case, the criteria 
for true resistance proposed by Greaves (1994) are not 
met. 
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Resistance Ratios 
If the LFP test is inappropriate for use with the 
potent second generation anticoagulants, how then should 
resistance to them be monitored'? The concept of the 
lethal feeding period was introduced in rodenticide 
resistance testing to overcome difficulties presented by the 
chronic nature of the first generation anticoagulants, such 
as warfarin, and the consequent requirement to administer 
them over several days for full effect. However, 
resistance to other pesticides (e.g. , insecticides) is more 
normally established by the comparison of dose-response 
data from susceptible and resistant strains in which the 
dose variable is an administered quantity of the compound 
in question, rather than a period of time. It seems 
Table 1. The data on the susceptibility of R. arge11tive111er to 0.25% warfarin (Buckle et at. 1980) are 
here used to demonstrate the effect of the model used to derive discriminating doses for use in checking 
tests for anticoagulant resistance using the WHO lethal feeding period method. 
Lethal feeding period (days) 
LFP percentile 
Probit/days Logit/days Probit/log days . Logit/log days 
LFP30 3.6 3.6 3.2 3.2 
LFP90 1.1 1.5 1.5 7.6 
LFPts 8.8 8.9 9.6 10.1 
LFP. 10.1 10.6 12.6 14.7 
LFP99 11.0 11.8 15.1 19.3 
• method of Finney (1971) recommended by WHO. 
sensible then to revert to this methodology with the 
second-generation anticoagulants which are active after 
single doses. 
Lethal dose (LO) percentiles can be determined in 
base-line experiments in which graded doses of the 
anticoagulant are given to groups of susceptible animals. 
To assess the resistance status of rodent populations, 
equivalent tests can be conducted with groups of suspected 
resistant animals and the relationship, at a certain LO 
percentile, between the potency of the active ingredient in 
susceptible and resistant animals expressed as a 
conventional •resistance ratio." Reference to established 
Norway rat resistance ratios for the second generation 
anticoagulants in existing resistance foci (Greaves 1994) 
would assist in determining the likely practical impact of 
any resistance detected. For tests on individual rodents, 
a certain LO percentile dose, say the L099 or a multiple 
of it, can be used in checking tests. Further work is 
required, however, to establish the potential of these 
proposals to provide effective and practicable resistance 
tests. Particularly, it is important to recognize that this 
technique would be expected to reflect accurately the 
resistance status of populations only when the frequency 
of the resistant phenotype is high. If the frequency is 
low, even a very high level of resistance in resistant 
individuals would not result in a significantly increased 
resistance ratio (Ward, personal observations). 
Blood Clotting Response CBCR) Tests 
As warfarin resistance (and cross-resistance to many 
of the other first generation anticoagulants) took hold in 
Norway rat populations in the UK, work began towards 
the development of more cost-effective tests to determine 
the resistance status of these rodents. This was because 
the tests described in the preceding paragraphs required 
either extensive field investigations or laboratory 
experiments of many weeks duration. Work on the 
biochemistry of resistance (Bell and Caldwell 1973) Jed to 
the observation that, in the Vitamin K cycle, the reduction 
of Vitamin K, epoxide to the quinone was Jess liable to 
inhibition by warfarin in resistant than in susceptible rats. 
Martin et al. (1979) used this effect in the development of 
a blood clotting response (BCR) test to distinguish 
warfarin resistant from warfarin susceptible Norway rats. 
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As in the previous tests, base-line observations were 
first required. Jn BCR tests the response variable is the 
reduction in blood clotting activity. This is measured as 
a clotting time and expressed as a percentage (of normal) 
coagulation activity (PCA). Coagulation times are 
determined using commercially available test methods 
(e.g., "Thrombotest") and converted to PCAs by 
reference to calibration curves. These curves are 
generated by determining coagulation times for a blood 
(or plasma) dilution series prepared form pooled blood 
samples from specific numbers of male and female 
animals. Thus, a blood sample with a PCA of 50 % has 
a coagulation time equivalent to that of a 50% dilution of 
the pooled normal blood sample. 
The next step in the development of the warfarin 
BCR test was to derive a discriminating dose of warfarin 
required to produce a specific effect on the blood 
coagulation of susceptible rats. (The effect chosen by 
Martin et al. (1979) was a reduction of blood clotting 
activity to less than 17 % of that seen in normal animals.) 
This was done by administering graduated doses of 
warfarin to groups of animals and observing, 24 hours 
later, their effect in preventing blood coagulation in 
different proportions of the animals tested. Vitamin K, 
epoxide was co-administered with the anticoagulant to 
reduce the tendency of resistant animals to become 
Vitamin K deficient. 
Martin et al. (1979) proposed a discriminating dose 
of 0 .5 mg of warfarin per 100 g of animal body weight. 
This was administered in saline solution with 0.1 mg per 
100 g of Vitamin K1 epoxide. When this dosage was 
given to 212 Norway rats, all warfarin resistant animals 
had PCAs that were greater than 17 % and all warfarin 
susceptible animals had a PCAs less than 17 % . Thus, the 
chosen dose was effective in discriminating resistant and 
susceptible Norway rats. The same authors went on to 
develop the test method further so that homozygous and 
heterozygous resistant animals could be distinguished. 
MacNicoll and Gill (1993a) revised this method, 
replacing Vitamin K1 epoxide with a water-soluble form 
of Vitamin K3 (menadione sodium bisulphite or MSB) and 
also using a water-soluble form of the anticoagulant, 
sodium warfarin. Jn the new test, both anticoagulant and 
vitamin are administered by oral intubation rather than by 
intraperitoneal injection. Subsequently, Gill et al. (1993) 
proposed a BCR test for difenacoum resistance and a test 
for resistance to bromadiolone is also available (Gill et al. 
1994). 
The doses of active ingredient and Vitamin K 
administered, the time from the administration of 
anticoagulant to measurement of PCA and the threshold 
PCA selected for each of these tests are summarii.ed in 
Table 2. 
Blood clotting response tests have a number of 
significant advantages. The tests are conducted in the 
laboratory and provide rapid assessments of the resistance 
status of individual rodents. They are not necessarily 
lethal to the animals tested because an effective dose of 
antidote can be administered after PCA assessment. This 
has benefits in the welfare of the animals used and 
permits the resistance status of individuals to be 
determined sequentially to a number of different 
compounds. It also allows animals to be used in later 
breeding studies in which the genetical basis of any 
resistance observed can be studied. The tests are very 
sensitive and can be used to detect small differences in the 
susceptibility of individual rodents to anticoagulants. 
However, some difficulties are associated with the 
use of the method. It relies on comparative measurements 
of the physiological effects of anticoagulants in susceptible 
and resistant rodents. Such observations provide no direct 
indication of the- practical impact of the resistance 
observed and further work is required for this to be to 
determined. Because of the sensitivity of the tests, 
relatively small differences in the susceptibility of rodent 
populations to anticoagulants can be demonstrated and 
there is a risk that naturally-occurring intraspecific 
variation can be classified as •resistance. • There is 
evidence that Vitamin K1 is antidotal to the effects of 
anticoagulants in resistant, but not in susceptible, rodents 
(MacNicoll and Gill 1993b). Therefore, care is required 
when using MSB to prevent resistant animals from 
becoming vitamin K deficient during BCR tests to avoid 
producing a confounding antidote effect. 
PRACTICAL USE OF RESISTANCE TESTS 
The most thoroughly researched anticoagulant 
resistance focus in the UK is the area in which warfarin-
resistant Norway rats infest farmsteads on the Anglo-
Welsh border. In this locality, the resistance monitoring 
graph has been used successfully in the assessment of 
novel, resistance-breaking anticoagulants (e.g., Rennison 
and Dubock 1978) and both LFP and BCR tests have 
been developed for resistance detection (Drummond and 
Wilson 1968, Martin et al. 1979). These tests accurately 
reflect a resistance situation in which warfarin is almost 
useless for the control of Norway rat populations 
containing a high percentage of resistant animals. 
Resistance in R. norvegicus to the second-generation 
compound, difenacoum, was reported on farms in central 
southern England soon after the introduction of the 
compound (Greaves et al. 1982). A WHO lethal feeding 
period test was established for the detection of 
difenacoum resistance (Redfern and Gill 1978) and, 
subsequently, a BCR test was also developed (Gill et al. 
1993). Rats were trapped from farms in the resistance 
area and found to be resistant to difenacoum using both 
detection methods. However, Greaves and Cullen-Ayres 
(1988) speculated that the level of resistance to 
difenacoum observed at the focus (the resistance ratio is 
four-fold) was insufficient to account for the severity of 
the practical problem. Later, extensive field studies 
revealed that control difficulties were primarily due to 
behavioral factors, principally the constant availability of 
alternative food sources that made the rat infestations very 
difficult to bait (Quy et al. 1992, Quy et al. these 
proceedings). 
A further focus of resistance to the second-generation 
anticoagulants was found to occur in Berkshire. At this 
site, rats are fully resistant, in practical terms, to 
bromadiolone (Prescott, personal observations) and work 
is in progress to determine a resistance ratio for this 
compound by the method proposed above. These 
infestations also contain individuals that survive the 
brodifacoum LFP test of Gill and MacNicoll (1991), 
Table 2. Some parameters used in blood clotting response tests for detecting resistance to anticoagulants in 
Norway rats. 
Type of Time (hrs) 
Discriminating dose· vitamin K Dose· of to checking Threshold 
Active ingredient of active ingredient used vitamin K PCA PCA 
Warfarin 0.5 K1 0.1 24 17 
Sodium warfarin 0.54 K1 0.1 24 17 
Difenacoum 0.5 K1 0.2 96 10 
Bromadiolone 0.1 K1 1.0 96 10 
(males) 
Bromadiolone 0.24 K1 1.0 96 10 
(females) 
• mg/kg per 100 g rat body weight 
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which involves feeding for seven days on 0.0005 % 
brodifacoum. However, none would be expected to 
survive feeding on full strength (i.e., 0.005%) 
brodifacoum baits and the efficacy ofbrodifacoum for the 
control of these infestations remains to be determined. 
These observations serve to illustrate the difficulties 
facing those who try to interpret, in terms of likely 
practical effect on rodent control, the results of laboratory 
experiments conducted to determine the resistance status 
of rodent populations. The foregoing also suggests that 
more research is required before statistically valid and 
fully reliable resistance detection methods are available. 
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